NY/NJ CEO
Date: Location: Cost:
November 7 - 8, 2017 Apella at Alexandria Center
450 E. 29 Street
New York, NY 10016
(212) 706-4100
Location >

Starting at $1950

 

Dress Code:
Business Attire

Register

NY/NJ CEO - November 7, 2017 - DRAFT

Co-hosts: Ron Cohen, President & CEO, Acorda; Ron CooperPresident & CEO, Albireo Pharma; Mikael DolstenPresident, WWRD, Pfizer; Carl GordonGeneral Partner, OrbiMed; Glenn GormleyExecutive Chairman & President, Daiichi Sankyo; Glenn KazoCEO, Prolong Pharmaceuticals; Ramesh KumarPresident & CEO, Onconova; Jonathan LewisChairman & CEO, Samus Therapeutics; Francois Nader, Chairman, Acceleron; Jonathan PeacockChairman & CEO, Arix Bioscience; Cynthia SchwalmEVP & President, North American Commercial Operations, IPSEN; Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche; Steve TregayCEO, FORMA Therapeutics; Harlan WaksalPresident & CEO, Kadmon

Time Agenda
7:30-8:20 am

Registration & Networking Breakfast

8:20-8:40 am

Welcome and Opening Remarks

8:40-9:10 am

Plenary Session: Major Issues for BioPharma in 2018 and Beyond
Ron Cohen, President & CEO, Acorda; Joaquin Duato, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson; Mani Mohindru, Chief Strategy Officer, Curis; Deepa Pakianathan, Managing Member, Delphi Ventures

9:10-9:30 am

Moderated Keynote: Emerging Areas of Unmet Needs
Mikael Dolsten
President, Worldwide R&D, Pfizer

9:30-10:00 am

State of the Markets: Biotech and Pharma
Robert Forrester, CEO, Verastem; Scott Myers, CEO, Cascadian Therapeutics; Simos SimeonidisManaging Director Biotechnology Equity Research, RBC Capital; Ron Squarer, CEO, Array BioPharma

10:00-10:30 am

Networking Break

10:30-11:00 am

Accessing Early Stage Innovation
Rekha Hemrajani, COO, FLX Bio; Julia Owens, President & CEO, Millendo Therapeutics; Brian McVeigh, VP, WWBD, GlaxoSmithKline; Jonathan Peacock, Chairman & CEO, Arix Bioscience
Moderator: Carl GordonGeneral Partner, OrbiMed

11:00-11:30 am

Alternative Financing Methods
Adam GridleyPresident & CEO, Histogenics; Uli Hacksell, CEO, Cerecor; Matthew Kane, CEO, Precision BioSciences; Glenn KazoPresident, Prolong Pharmaceuticals; Pedro Lichtinger, former CEO, Asterias; Maria Maccecchini, President & CEO, QR Pharma

11:30-12:00 pm

Therapeutic Market Focus: Oncology & Immunotherapy
Parker Cassidy, CCO, Mitra Biotech; Jimmy Lin, CSO, Oncology, Natera; Ramon Mohanlal, CMO, BeyondSpring Pharmaceuticals; Daniel Teper, CEO, IMMUNE Pharmaceuticals; Maurice Zauderer, President & CEO, Vaccinex

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Big Pharma and Biotech: Impact on Innovation
Rivka Kreitman, SVP, Head, Global Search & Evaluation, Teva; Philippe Lopes-FernandesSVP, Global Head of BD & Alliance Management, EMD Serono; Harlan Waksal, President & CEO, Kadmon
Moderator: L.E.K. Consulting

1:30-2:00 pm

Ensuring Transparency and Drug Value
Luigi CostaCEO, Nordic Nanovector; Cedric Francois, President & CEO, Apellis Pharmaceuticals; Ramesh Kumar, President & CEO, Onconova; Thomas Lonngrenformer Executive Director, EMA; Niven Narain, Co-Founder, President & CEO, Berg; Sam Waksal, Founder, Kadmon

2:00-2:20 pm

Fireside Chat
Ron Cohen, President & CEO, Acorda

2:20-2:50 pm

Networking Break

2:50-3:20 pm

Accessing Innovation in Drug Discovery: Where and How?
John Haurum, CEO, F-star Biotechnology; Michael Foley, Sanders Director, Tri-Institutional Therapeutics Discovery Institute; Julie Krop, CMO & SVP Clinical Development & Regulatory Affairs, AMAG Pharmaceuticals; Jonathan Lewis, CEO, Samus Therapeutics; Gregory VerdineCEO, Fog Pharmaceuticals

3:20-3:50 pm

Partner or Go it Alone
Ivana Magovcevic-Liebisch
EVP, Chief Strategy & Corp. Dev Officer, Axcella Health; Rasmus Toft-Kehler, CEO, AntibioTx
Moderator: Mark Simon, Partner, Torreya Partners

3:50-4:10 pm

Moderated Keynote

4:10-5:00 pm

Cocktails & Hors d’oeuvres

NY/NJ CEO - November 8, 2017 - DRAFT

Co-hosts: Ron Cohen, President & CEO, Acorda; Ron CooperPresident & CEO, Albireo Pharma; Mikael DolstenPresident, WWRD, Pfizer; Carl GordonGeneral Partner, OrbiMed; Glenn GormleyExecutive Chairman & President, Daiichi Sankyo; Glenn KazoCEO, Prolong Pharmaceuticals; Ramesh KumarPresident & CEO, Onconova; Jonathan LewisChairman & CEO, Samus Therapeutics; Francois Nader, Chairman, Acceleron; Jonathan PeacockChairman & CEO, Arix Bioscience; Cynthia SchwalmEVP & President, North American Commercial Operations, IPSEN; Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche; Steve TregayCEO, FORMA Therapeutics; Harlan WaksalPresident & CEO, Kadmon

Time Agenda
7:30-8:30 am

Registration & Networking Breakfast

8:30-8:45 am

Welcome and Opening Remarks

8:45-9:15 am

Healthcare Market Dynamics: Predictions for 2018
Arthur Hiller, CEO, Antyllus; Martin Lehr, CEO, Context Therapeutics; Francois NaderChairman, Acceleron Pharma; Hamza Suria, President & CEO, AnaptysBio

9:15-9:45 am

Therapeutic Market Focus: Microbiome
Karim Dabbagh, CSO, Second Genome; Xavier Duportet, CEO & Chairman, Eligo Bioscience; Bernat OlleCEO, Vedanta Biosciences; Todd Patrick, President & CEO, C3J Therapeutics; Jeff Riley, CEO, Synthetic Biologics
Moderator: Lee JonesPresident & CEO, Rebiotix

9:45-10:15 am

AI and Disruptive Innovation

10:15-10:45 am

Networking Break

10:45-11:15 am

Rare Disease Economics: Impact on the Industry
Anil Diwan, President & Chairman, NanoViricides; Dipal Doshi, CBO, Amicus; Shalabh GuptaFounder & CEO, Globavir; Ken Moch, Managing Partner, Salutramed; David Soergel, CMO, Trevena

11:15-11:45 pm

Small-Cap and Private Biotech: Leveraging Potential
Alan EzekowitzPresident & CEO, Abide Therapeutics; Gregory Mario, President & CEO, Taxis Pharmaceuticals; Helen Montag, Senior Director, Johns Hopkins Technology Ventures; Joseph Payne, President & CEO, Arcturus Therapeutics

11:45-12:15 pm

Venture Financing: Maintaining Momentum
Bernard Davitian, VP & Managing Director, Sanofi-Genzyme BioVentures; Jan-Anders KarlssonCEO, Verona Pharma; Nick Naclerio, Founder & Managing Director, Illumina Ventures; Carlo Rizzuto, Partner, Versant Ventures

12:15-1:00 pm

Networking Lunch

1:00-1:20 pm

Fireside Chat

1:20-1:50 pm

Global Markets: Biotechs Across Borders
Carl Firth, CEO, Aslan Pharmaceuticals; Rachel Humphrey, SVP & CMO, CytomX

1:50-2:20 pm

Innovative Deals and Partnerships
John DeYoung, VP, Oncology BD, Pfizer; Elcin Ergun, President, New Businesses, EMD Serono; Cynthia Schwalm, EVP & President, Commercial Operations, North America, Ipsen
Moderator: Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche

2:20-2:50 pm

Networking Break

2:50-3:20 pm

Biotech Valuations in 2017
Leland Gershell, CFO, Capricor Therapeutics; Anna Kazanchyan, Chairman & CEO, Saghmos Therapeutics; Brian LeuthnerPresident & CEO, Edge Therapeutics

3:20-3:50 pm

Building a Biotech: Innovative Business Models
Ron Cooper
President & CEO, Albireo Pharma
Moderator: Steve Tregay, CEO, Forma Therapeutics

3:50-4:10 pm

Fireside Chat
George Yancopoulos, President & CSO, Regeneron

4:10-4:30 pm

Presentation of NY/NJ CEO Lifetime Achievement Award
Presented by: Francois Nader, 2016 Honoree; Ron Cohen, 2013 Honoree; George Yancopoulos, 2012 Honoree

4:30-5:30 pm

Cocktails & Hors d'oeuvres

Premier Sponsors: (see all sponsors)

<